EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multimodal data fusion: integrating PET/MRI and liquid biopsy for a holistic view of cancer biology

Yuying Zhao, Bo Shen, Wei Luo, Mingli Wang

Frontiers in Oncology · 08.05.2026 · 16

DOI: 10.3389/fonc.2026.1775271 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 08.05.2026. Verfasst von Yuying Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huzhou Central Hospital, Huzhou, Zhejiang, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The systemic complexity and spatiotemporal heterogeneity of cancer demand diagnostic strategies beyond single modalities. The integration of positron emission tomography/magnetic resonance imaging (PET/MRI) with liquid biopsy offers a revolutionary paradigm for a comprehensive view of tumor biology. This approach synergizes PET/MRI’s high-resolution spatial information—covering anatomical, functional, and metabolic characteristics—with the systemic, dynamic molecular data from liquid biopsy, particularly circulating tumor DNA (ctDNA). This review systematically examines the principles of this synergy, analyzing multimodal data fusion strategies, clinical evidence, and future challenges. The central benefit of this fusion is the enhancement of clinical decision-making across the cancer care continuum: improving early diagnosis and localization, resolving spatial heterogeneity, enabling dynamic monitoring of treatment efficacy, and tracing drug resistance. Current evidence, though primarily from retrospective or proof-of-concept studies, strongly supports this potential. However, significant challenges persist in technical standardization, algorithmic development for integrating heterogeneous data, and the need for large-scale prospective validation. Propelled by advances in artificial intelligence, overcoming these hurdles will shift oncology from static diagnostics toward a new era of precision medicine, capable of dynamically mapping the entire tumor ecosystem to deliver truly individualized patient care.

Schlagwörter

Stichwörter der Autor:innen

CtDNAPET/MRIliquid biopsymultimodal data fusionprecision medicine

Autor:innen und Institutionen

  • Department of Radiology, Huzhou Central Hospital, Huzhou, Zhejiang, China.

Zitieren

APA

Zhao, Y., Shen, B., Luo, W., & Wang, M. (2026). Multimodal data fusion: integrating PET/MRI and liquid biopsy for a holistic view of cancer biology. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1775271

Vancouver

Zhao Y, Shen B, Luo W, Wang M. Multimodal data fusion: integrating PET/MRI and liquid biopsy for a holistic view of cancer biology. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1775271

BibTeX
@article{Zhao2026,
  author = {Zhao, Yuying and Shen, Bo and Luo, Wei and Wang, Mingli},
  title = {Multimodal data fusion: integrating PET/MRI and liquid biopsy for a holistic view of cancer biology},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1775271}
}
Kostenlos starten →